Federal Register / Vol. 62, No. 176 / Thursday, September 11, 1997 / Notices 47821

Dated: September 5, 1997.

Michael H. Trujillo,

Assistant Surgeon General, Director.

[FR Doc. 97–24118 Filed 9–10–97; 8:45 am]

BILLING CODE 4160–16–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of

Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Alternative Medicine Program Advisory

Council on September 22–23, 1997,

Natcher Conference Center, 45 Center

Drive, 9000 Rockville Pike, Conference

Room D, Bethesda, Maryland 20892.

The two-day meeting will be open to

the public from 7:30 a.m. to 4:30 p.m.

on September 22 and 8:30 a.m. to 3:30

p.m. on September 23. Attendance by

the public will be limited to space

available. The purpose of the meeting

will be to update and review the

progress of the Office of Alternative

Medicine and obtain Council’s advise

on research activities. Additional

agenda items include: (1) Orientation

and introduction of new members; (2) a

presentation on ‘‘Homeopathic

Treatment of Traumatic Brain Injury’’;

(3) a presentation on ‘‘Protopine from

Corydalis Ternata’’ has Anticholinesterase and Anti-Amnesic

Activities; (4) discussion of the strategic

plan; and (5) other activities of the

Council.

Ms. Mary Plummer, Committee

Management Officer, Office of

Alternative Medicine, 6100 Executive

Boulevard, 6100 Building, Room 5E01,

National Institutes of Health, Bethesda,

Maryland 20892–7510, Area Code 301–

594–7232, will provide a summary of

the meeting and a roster of Council

members as well as substantive program

information. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

contact Ms. Plummer no later than

September 15, 1997.

Dated: September 4, 1997.

LaVerne Stringfield,

Committee Management Officer, NIH.

[FR Doc. 97–24051 Filed 9–10–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Division of Research Grants; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Biological and Physiological

Sciences.

Date: October 13–15, 1997.

Time: 7:00 p.m.

Place: Sheraton Bradley International

Hotel, Hartford, CT.

Contact Person: Dr. Harish Chopra,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5112, Bethesda,

Maryland 20892, (301) 435–1169.

Name of SEP: Biological and Physiological

Sciences.

Date: November 6–7, 1997.

Time: 8:30 a.m.

Place: Holiday Inn, Bethesda, MD.

Contact Person: Dr. Syed Amir, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 6168, Bethesda, Maryland 20892, (301)

435–1043.

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Chemistry and Related

Sciences.

Date: November 12–13, 1997.

Time: 8:00 a.m.

Place: Georgetown Holiday Inn,

Washington, DC.

Contact Person: Dr. Donald Schneider,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4172, Bethesda,

Maryland 20892, (301) 435–1727.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HIS.

Dated: September 4, 1997.

LaVerne Y. Springfield,

Committee Management Officer, NIH.

[FR Doc. 97–24050 Filed 9–10–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

National Institute of Environmental

Health Sciences; National Toxiology

Program Request for Comments on

Chemicals Nominated to the National

Toxicology Program (NTP) for

Toxicological Studies—

Recommendations by the Interagency

Committee for Chemical Evaluations

and Coordination (ICCEC) for Study,

No Studies, or Deferral To Obtain

Further Supporting Information

Background

As part of an effort to earlier inform

and obtain public input into the

selection of chemicals for evaluation,

the National Toxicology Program (NPT)

routinely seeks public input on (1)

chemicals nominated to the Program for

toxicological studies, and (2) the testing

recommendations made by the

Interagency Committee for Chemical

Evaluation and Coordination (ICCEC).

Summaries of the ICCEC’s

recommendations and public comments

received on the nominated chemicals

are next presented to the NTP Board of

Scientific Counselors for their review

and comment in an open, public

session. ICCEC recommendations, Board

recommendations, and public

comments are incorporated into

recommendations that are then

submitted to the NTP Executive

Committee. The Executive Committee

reviews and approves action to move

forward to test, defer, or delete each of

the nominated chemicals for the various

types of study, and recommends

priorities.

Request for Comment

Interested parties are encouraged to

comment and provide information on

the chemicals listed below. The Program

would welcome receiving toxicology

and carcinogenesis information from

completed or ongoing studies, and

information on planned studies, as well

as current production data, human

exposure information, use patterns, and

environmental occurrence for any of the

chemicals listed in this announcement.

To provide comments or information,

please contact Dr. William Eastin at the

address given below within 60 days of

the appearance of this announcement.

At its meeting on August 15, 1997, the

ICCEC reviewed and recommended 4

chemicals or substances for toxicity

and/or carcinogenicity studies,

recommended that no studies be

performed on 5 chemicals, and deferred

4 chemicals pending receipt of test data
47822 Federal Register / Vol. 62, No. 176 / Thursday, September 11, 1997 / Notices

from other agencies, and additional

information on production, exposure,

and use patterns. Chemicals with CAS

numbers, nomination source, types of

studies recommended, and other

supporting information, are given in the

following tables.

Comments may be forwarded by mail

to: Dr. William Eastin, NIEHS/NTP, P.O.

Box 12233, Research Triangle Park,

North Carolina 27709; by telephone at

(919) 541–7941; by FAX at (919) 541–

4714; or by email at

Eastin@NIEHS.NIH.GOV.

Dated: August 29, 1997.

Kenneth Olden,

Director, National Toxicology Program.

Chemicals Nominated to the NTP for Study and Testing; Recommendations Made by the ICCEC on August 15, 1997

Chemical CASRIN Nomin. by Recommended for Rationale; other info.

Chemicals Recommended for Testing

Asphalt fumes ......... 8052–42–4 NIOSH; Calif .......... —28-day toxicological assessment .......

—plumonary function and irritation ........

biomarkers of exposure .........................

—high exposure

—lack of adequate short term toxicity

information

—need to identify

—biomarkers of exposure

Luminol (oAminophthalic hydrazide).521–31–3 private indiv.,

NIOSH.

—toxicity ................................................

—carcinogenicity ....................................

in vivo genetic toxicity ............................

—widespread use and potential for exposure

Orthanilic acid ......... 88–21–1 NIEHS .................... —short-term toxicity studies .................. —high production

—very little toxicology data available

Phenothiazine ......... 92–84–2 NIEHS .................... —carciogenicity ...................................... —high production and exposure

—no carcinogencity data available

Chemicals for Which No Testing is Recommended

Dicyclopentadiene ... 77–73–6 NCI ......................... —reproductive toxicity ...........................

—carcinogenicity ....................................

—no adverse effects seen in teratology

tests

—not mutagenic in Salmonella

—low potential for human exposure

C.I. Direct Black 80 8003–69–8 NCI ......................... —carcingoenicity by dermal route ......... —dermal absorption too low (1.3%) to

support a study

Ethyl cyanoacrylate 7085–85–0 NCI ......................... —reproductive and developmental toxicity.

neurotoxicity ...........................................

—carcinogenicity ....................................

—stable aerosol cannot be generated

—rapidly polymerizes in presence of atmospheric moisture

Isoamyl acetate ....... 123–92–2 NIEHS .................... —toxicity ................................................

—neurotoxicity .......................................

—carcinogenicity ....................................

—rapdily hydrolyzed in blood to isoamyl

alcohol, which has been studied, and

acetic acid

2,4,6-

Tribromophenol.

118–79–6 HIEHS .................... —carcinogenicity .................................... —low production and exposure

—little chance for bioaccumulation

Chemicals Deferred for Additional Information

3-Amino-5-mercapto-1,2,4-triazole.16691–43–3 NIEHS .................... —toxicity; carcinogenicity ....................... —high production

—suspect chemical structure

Diethylamine ........... 109–89–7 NIEHS .................... —toxicity; carcinogenicity ....................... —high production and exposure

—very little toxicology data available

—not mutagenic in Salmonella

Isopropylamine ........ 75–31–0 NIEHS .................... —toxicity; carcinogenicity ....................... —high production and exposure

—very little toxicology data available

—not mutagenic in Salmonella

Triethylamine .......... 121–44–8 UAW; NIEHS ......... —carcinogenicity .................................... —high production and exposure

—not mutagenic in Salmonella

[FR Doc. 97–24048 Filed 9–10–97; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Substance Abuse and Mental Health

Services Administration (SAMHSA)

Notice of Meetings

Pursuant to Public Law 92–463,

notice is hereby given of the following

meetings of the SAMHSA Special

Emphasis Panel I in September and

Special Emphasis Panel II in October.

A summary of the meetings and

rosters of the members may be obtained

from: Ms. Dee Herman, Committee

Management Liaison, SAMHSA Office

of Extramural Activities Review, 5600

Fishers Lane, Room 17–89, Rockville,

Maryland 20857. Telephone: 301–443–

7390.

Substantive program information may

be obtained from the individual named

as Contact for the meetings listed below.

The Special Emphasis Panel I meeting

will include the review, discussion and

evaluation of individual grant

applications. These discussions could

reveal personal information concerning

individuals associated with the

applications. Accordingly, this meeting

is concerned with matters exempt from